Skip to main content Help with accessibility Skip to main navigation

TIOTROPIUM inhalation (Spiriva Respimat®▼) for asthma in children and young people

CCG Approval Status:

Date Added: 24 - May - 2018
Body System:
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of TIOTROPIUM inhalation (Spiriva Respimat®▼) for asthma in children and young people < 18 years of age.